| Revenue growth | Q2 +22% YoY consolidated; H1 +16% |
|---|---|
| Margins | Q2 EBITDA 31.2% vs 36.4% YoY; RM costs 43.3% |
| Demand visibility | HALS volumes doubled; new segment scaling |
Growth
H1 FY27 consolidated revenue ₹568 Cr (+16%); PAT ₹129 Cr (+3%). HALS segment grew 2x in H1 and is now 22% of sales.
Outlook
CFCL HALS commercial launch and Performance Chemical 2 expected H2 FY27. ~₹150 Cr H1 capex into CFCL. No numeric guidance given.
Risks
Raw material costs rose to 43.3% of sales, compressing EBITDA margin to 31.2%. Standalone PAT fell 14% YoY on geopolitical headwinds.
Last quarter's promises, checked
Delivered
- Guided gradual revenue rise as HQ/catechol ramps → Q2 ₹299 Cr vs Q1 ₹264 Cr, +13% QoQ (= BEAT)
Partly delivered
- Guided HALS ₹250–300 Cr FY27 → HALS 22% of sales, H1 2x; ₹ value not disclosed (= PARTIAL)
- Guided HQ/catechol revenue from Aug–Sep 2026 → 'ramping up for commercial supplies'; no revenue figure (= PARTIAL)
- Guided Performance Chemical 2 commercial by Nov-ish 2026 → still 'expected H2 FY27' (= PARTIAL)
Missed
- Guided EBITDA margins 'will keep improving' → Q2 31.2% vs Q1 37% (= MISS)
Investor Presentation filed with BSE, NSE: CLEAN. Summary written with AI assistance from the document.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹715.60
- Market cap
- ₹7,606 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 32.6×Sector 34.1×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 0.5% YoY
Clean Science & Technology Ltd reported revenue from operations of ₹299.4 Cr (+22.4% YoY) and net profit of ₹55.7 Cr (+0.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹55.7 Cr · +0.5% YoY
Clean Science & Technology Business Update
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
Clean Science & Technology Other Announcement
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.
Clean Science & Technology Legal & Regulatory
Clean Science concluded GST proceedings, resulting in a ₹2.0 crore net financial impact. A further ₹9.9 crore liability is recoverable as Input Tax Credit.
- Value
- ₹11.90 Cr
Clean Science & Technology Credit Rating
CRISIL reaffirmed Clean Science's long-term rating at AA-/Stable and short-term at A1+. The rating action signals continued stable credit quality with no change.